News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

April

30

TriSalus Life Sciences Secures up to $50 Million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives

DENVER–(BUSINESS WIRE)–Apr. 30, 2024– TriSalus Life Sciences Inc., (Nasdaq: TLSI), today announced the closing of...